1.2900
-0.1100
(-7.86%)
As of 12:15:28 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.25 | -0.25 | -0.94 | -1.09 |
| Low Estimate | -0.25 | -0.25 | -0.94 | -1.09 |
| High Estimate | -0.25 | -0.25 | -0.94 | -1.09 |
| Year Ago EPS | -0.56 | -0.48 | -1.65 | -0.94 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.62 | -0.59 | -0.39 | -0.34 |
| EPS Actual | -0.56 | -0.48 | -0.35 | -0.25 |
| Difference | 0.06 | 0.11 | 0.03 | 0.09 |
| Surprise % | 9.68% | 18.99% | 8.97% | 25.88% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.25 | -0.25 | -0.94 | -1.09 |
| 7 Days Ago | -0.3 | -0.24 | -1.44 | -1.09 |
| 30 Days Ago | -0.26 | -0.25 | -1.25 | -1.02 |
| 60 Days Ago | -0.23 | -0.25 | -1.16 | -1.02 |
| 90 Days Ago | -0.23 | -0.25 | -1.16 | -1.02 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | 2 | 1 | 2 | -- |
| Down Last 7 Days | -- | 1 | 1 | 1 |
| Down Last 30 Days | -- | 1 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ANTX | 55.36% | 47.92% | 42.88% | -15.96% |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/26/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 2/25/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/3/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 11/19/2024 |
| Downgrade | TD Cowen: Buy to Hold | 11/18/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/9/2024 |
Related Tickers
HLVX HilleVax, Inc.
1.4400
-0.69%
EPIX ESSA Pharma Inc.
1.5150
-4.10%
THRD Third Harmonic Bio, Inc.
3.3800
-5.31%
SPRO Spero Therapeutics, Inc.
0.5968
-4.36%
KZR Kezar Life Sciences, Inc.
4.0500
-10.00%
IKNA Ikena Oncology, Inc.
1.1500
-4.17%
BOLT Bolt Biotherapeutics, Inc.
0.3726
-5.77%
ASMB Assembly Biosciences, Inc.
8.72
-6.34%
GLTO Galecto, Inc.
2.7250
-4.72%
RPTX Repare Therapeutics Inc.
1.0100
-3.81%